ExpreS2ion Biotech Holding AB (EXPRS2) — Capital Reinvestment Ratio

Latest as of March 2024: 0.22x

ExpreS2ion Biotech Holding AB (EXPRS2) has a Capital Reinvestment Ratio of 0.22x as of March 2024, meaning it reinvests 0% of its operating cash flow (Skr854.00K) in capital expenditures (Skr189.00K). See EXPRS2 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.22x

Capex / Operating Cash Flow

Operating Cash Flow

Skr854.00K

SEK

Capital Expenditures

Skr189.00K

SEK

Data as of

Mar 2024

Most recent filing

Annual Capital Reinvestment Ratio for ExpreS2ion Biotech Holding AB (None–None)

Year-by-year Capital Reinvestment Ratio for ExpreS2ion Biotech Holding AB from None to None. For live market cap and broader valuation context, see ExpreS2ion Biotech Holding AB market capitalisation.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow